Finn Patrick John bought TWST
February 17, 2026 · Form 4 insider transaction
Finn Patrick John bought 32,300 shares of Twist Bioscience Corporation at $26.66 per share, a transaction worth $861.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,300
Price
$26.66
Total value
$861.1K
InsiderFinn Patrick John
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after356,755
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 13, 2025.